CMX001 is a potential treatment for Adenovirus infection: Preliminary antiviral activity results from an open-label, expanded access study of CMX001 for the treatment of serious or life-threatening diseases caused by double-stranded DNA viruses Meeting Abstract

  


Authors: Grimley, M.; Papanicolaou, G.; Prasad, V.; Dropulic, L.; Mommeja-Marin, H.; Brundage, T.; Chittick, G.; Margolskee, D.
Abstract Title: CMX001 is a potential treatment for Adenovirus infection: Preliminary antiviral activity results from an open-label, expanded access study of CMX001 for the treatment of serious or life-threatening diseases caused by double-stranded DNA viruses
Meeting Title: 39th Annual Meeting of the European Group for Blood and Marrow Transplantation
Journal Title: Bone Marrow Transplantation
Volume: 48
Issue: Suppl.2
Meeting Dates: 2013 Apr 7-10
Meeting Location: London, England
ISSN: 0268-3369
Publisher: Nature Publishing Group  
Date Published: 2013-04-01
Start Page: S56
End Page: S57
Language: English
ACCESSION: WOS:000319025200124
PROVIDER: wos
Notes: --- - Meeting Abstract: O368 - 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT) - APR 07-10, 2013 - London, ENGLAND - "2" - "Source: Wos"